Brooker Simon, Bethony Jeffrey, Hotez Peter J
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Adv Parasitol. 2004;58:197-288. doi: 10.1016/S0065-308X(04)58004-1.
The scientific study of human hookworm infection began at the dawn of the twentieth century. In recent years, there have been dramatic improvements in our understanding of many aspects of this globally widespread parasite. This chapter reviews recent advances in our understanding in the biology, immunology, epidemiology, public health significance and control of hookworm, and to look forward to the study of this important parasite in the 21st century. Advances in molecular biology has lead to the identification of a variety of new molecules from hookworms, which have importance either in the molecular pathogenesis of hookworm infection or in the host-parasite relationship; some are also promising vaccine targets. At present, relatively little is known about the immune responses to hookworm infection, although it has recently been speculated that hookworm and other helminths may modulate specific immune responses to other pathogens and vaccines. Our epidemiological understanding of hookworm has improved through the development of mathematical models of transmission dynamics, which coupled with decades of field research across multiple epidemiological settings, have shown that certain population characteristics can now be recognised as common to the epidemiology, population biology and control of hookworm and other helminth species. Recent recognition of the subtle, but significant, impact of hookworm on health and education, together with the simplicity, safety, low cost and efficacy of chemotherapy has spurred international efforts to control the morbidity due to infection. Large-scale treatment programmes are currently underway, ideally supported by health education and integrated with the provision of improved water and sanitation. There are also on-going efforts to develop novel anthelmintic drugs and anti-hookworm vaccines.
对人体钩虫感染的科学研究始于20世纪初。近年来,我们对这种全球广泛存在的寄生虫的许多方面的认识有了显著提高。本章回顾了我们在钩虫生物学、免疫学、流行病学、公共卫生意义及防治方面认识的最新进展,并展望21世纪对这种重要寄生虫的研究。分子生物学的进展已促使从钩虫中鉴定出多种新分子,这些分子在钩虫感染的分子发病机制或宿主 - 寄生虫关系中具有重要意义;有些还是很有前景的疫苗靶点。目前,对钩虫感染的免疫反应了解相对较少,尽管最近有人推测钩虫和其他蠕虫可能会调节对其他病原体和疫苗的特异性免疫反应。通过传播动力学数学模型的发展,我们对钩虫流行病学的认识有所提高,该模型与在多种流行病学环境中进行的数十年实地研究相结合,表明某些人群特征现在可被视为钩虫及其他蠕虫种类的流行病学、种群生物学和防治所共有的特征。最近认识到钩虫对健康和教育的微妙但重大的影响,再加上化疗的简便性、安全性、低成本和有效性,促使国际社会努力控制感染所致的发病率。目前正在开展大规模治疗项目,理想情况下辅以健康教育,并与改善供水和卫生设施相结合。此外,正在努力开发新型驱虫药物和抗钩虫疫苗。